Lilly announces departure of Anat Ashkenazi, chief financial officer

INDIANAPOLIS, June 5, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that Anat Ashkenazi has resigned as chief financial officer to pursue a career opportunity outside of the pharmaceutical industry. "On behalf of our board of directors, leadership team and employees, I would like to thank Anat for her 23 years of outstanding service to our company," said David A. Ricks, Lilly's chair and CEO. "During her last three years as Lilly's CFO, we have experienced tremendous growth and laid ...